Title:
Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson’s Disease

dc.contributor.authorNidhi Sachan
dc.contributor.authorNeha Tiwari
dc.contributor.authorDevendra Kumar Patel
dc.contributor.authorDiksha Katiyar
dc.contributor.authorSaripella Srikrishna
dc.contributor.authorMahendra Pratap Singh
dc.date.accessioned2026-02-07T11:26:28Z
dc.date.issued2023
dc.description.abstractThe etiology of Parkinson’s disease (PD) is highly complex and is still indefinable. However, a number of studies have indicated the involvement of pesticides and transition metals. Copper, magnesium, iron, and zinc have emerged as important metal contributors. Exposure to pesticides causes an accumulation of transition metals in the substantia nigra (SN) region of the brain. The cypermethrin model of PD is characterized by mitochondrial dysfunction, autophagy impairment, oxidative stress, etc. However, the effect of cypermethrin on metal homeostasis is not yet explored. The study was designed to delineate the role of metals and their transporter proteins in cypermethrin-induced animal and cellular models of PD. The level of copper, magnesium, iron, and zinc was checked in the nigrostriatal tissue and serum by atomic absorption spectroscopy. Since cypermethrin consistently increased iron content in the nigrostriatal tissue and serum after 12 weeks of exposure, the level of iron transporter proteins, such as divalent metal transporter-1 (DMT-1), ceruloplasmin, transferrin, ferroportin, and hepcidin, and their in silico interaction with cypermethrin were checked. 3,3′-Diaminobenzidine-enhanced Perl’s staining showed an elevated number of iron-positive cells in the SN of cypermethrin-treated rats. Molecular docking studies revealed a strong binding affinity between cypermethrin and iron transporter protein receptors of humans and rats. Furthermore, cypermethrin increased the expression of DMT-1 and hepcidin while reducing the expression of transferrin, ceruloplasmin, and ferroportin in the nigrostriatal tissue and human neuroblastoma cells. These observations suggest that cypermethrin alters the expression of iron transporter proteins leading to iron dyshomeostasis, which could contribute to dopaminergic neurotoxicity. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
dc.identifier.doi10.1007/s12035-023-03436-2
dc.identifier.issn8937648
dc.identifier.urihttps://doi.org/10.1007/s12035-023-03436-2
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/44423
dc.publisherSpringer
dc.subjectCypermethrin
dc.subjectIn silico studies
dc.subjectIron dyshomeostasis
dc.subjectIron transporter proteins
dc.subjectParkinson’s disease
dc.titleDyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson’s Disease
dc.typePublication
dspace.entity.typeArticle

Files

Collections